| 1414 Degrees Limited (14D) ORDINARY FULLY PAID |
Industrials |
$50 |
Change in substantial holding
|
21 Oct 2025 9:13AM |
$0.039 |
$0.074 |
risen by
89.74%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,723 |
Appendix 3C
|
21 Oct 2025 9:13AM |
$45.630 |
$45.200 |
fallen by
0.94%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,723 |
Appendix 3C
|
21 Oct 2025 9:13AM |
$45.630 |
$45.200 |
fallen by
0.94%
|
|
| FOS Capital Ltd (FOS) ORDINARY FULLY PAID |
Industrials |
$8 |
Application for quotation of securities - FOS
|
21 Oct 2025 9:12AM |
$0.250 |
$0.120 |
fallen by
52%
|
|
| Adelong Gold Limited (ADG) ORDINARY FULLY PAID |
Materials |
- |
Soil sampling commences at Apollo Gold Project
|
21 Oct 2025 9:12AM |
$0.015 |
$0.005 |
fallen by
66.67%
|
|
ADG - Price-sensitive ASX Announcement
Full Release
Key Points
- Regional soil sampling commenced at Apollo Gold Project.
- The program covers 11km along Strathbogie Granite contact.
- Objective is to identify structures analogous to Apollo mineralisation.
- Follows successful diamond drilling campaign confirming gold mineralisation.
- Data will refine exploration targets and guide future drilling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pure Hydrogen Corporation Limited (PH2) ORDINARY FULLY PAID |
Energy |
- |
Settlement of Contractual Claim and Business Acquisition
|
21 Oct 2025 9:11AM |
$0.090 |
$0.085 |
fallen by
5.56%
|
|
| Tartana Minerals Limited (TAT) ORDINARY FULLY PAID |
Materials |
$9 |
High Grade Cu and Au at Muscleville and Molloy Acquisition
|
21 Oct 2025 9:10AM |
$0.041 |
$0.022 |
fallen by
46.34%
|
|
TAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Tartana Minerals Limited completed the acquisition of the Molloy Regional Project.
- The Molloy Project is situated approximately 35 kilometres west of Palm Cove, Queensland.
- The project area includes historically significant copper and zinc mineralisation sites.
- Tartana aims to identify bulk-tonnage, open-pittable gold and copper targets in the region.
- The acquisition complements Tartana's existing projects, expanding their footprint in the Hodgkinson Province.
- The Muscleville exploration program returned promising assays, including high-grade copper and gold results.
- Significant exploration work was conducted, including airborne magnetic and radiometric surveys.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$49 |
Australian Patent Granted for NUZ-001
|
21 Oct 2025 9:09AM |
$0.135 |
$0.064 |
fallen by
52.59%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Australian patent granted for NUZ-001 for neurodegenerative diseases.
- Patent complements existing US patent for unified global protection until May 2041.
- NUZ-001 is being prepared for entry into the HEALEY ALS Platform Trial.
- Neurizon aims to accelerate development via Australian clinical trial capabilities.
- The patent strengthens Neurizon's global intellectual property position.
- NUZ-001 is positioned as a potential treatment for diseases with limited options.
- Neurizon remains committed to pre-clinical programs for NUZ-001.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Calix Limited (CXL) ORDINARY FULLY PAID |
Materials |
$78 |
Calix Presentation - 14th Australian Microcap Conference
|
21 Oct 2025 9:07AM |
$0.470 |
$0.360 |
fallen by
23.40%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$741 |
Update - Notification of buy-back - RF1
|
21 Oct 2025 9:07AM |
$3.340 |
$3.560 |
risen by
6.59%
|
|
| xReality Group Ltd (XRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$51 |
2025 Notice of Annual General Meeting
|
21 Oct 2025 9:07AM |
$0.058 |
$0.068 |
risen by
17.24%
|
|
| Adherium Limited (ADR) ORDINARY FULLY PAID |
Health Care |
$7 |
Update - Notification regarding unquoted securities - ADR
|
21 Oct 2025 9:06AM |
$0.005 |
$0.130 |
risen by
2,500%
|
|
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$2,832 |
Notification of cessation of securities - MFG
|
21 Oct 2025 9:06AM |
$10.350 |
$9.680 |
fallen by
6.47%
|
|
| Magnum Mining and Exploration Limited (MGU) ORDINARY FULLY PAID |
Materials |
$19 |
Change in substantial holding
|
21 Oct 2025 9:05AM |
$0.010 |
$0.006 |
fallen by
40%
|
|
| Pathkey.AI Ltd (PKY) ORDINARY FULLY PAID |
Information Technology |
$50 |
Board and Management Transition
|
21 Oct 2025 9:05AM |
$0.024 |
$0.040 |
risen by
66.67%
|
|
| Redcastle Resources Limited (RC1) ORDINARY FULLY PAID |
Materials |
$17 |
Consolidation/Split - RC1
|
21 Oct 2025 9:05AM |
$0.010 |
$0.125 |
risen by
1,150%
|
|
RC1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Security consolidation for Redcastle Resources Limited
- Consolidation ratio: 10 pre-consolidation securities to 1 post-consolidation security
- Security holder meeting on November 27, 2025
- Last trading day for pre-consolidation securities on November 28, 2025
- Deferred trading of post-consolidation securities begins on December 1, 2025
- Record date for consolidation is December 2, 2025
- Issue date for updated securities is December 9, 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Redcastle Resources Limited (RC1) ORDINARY FULLY PAID |
Materials |
$17 |
Share Consolidation and Loyalty Option Entitlement Offer
|
21 Oct 2025 9:04AM |
$0.010 |
$0.125 |
risen by
1,150%
|
|
| Argenica Therapeutics Limited (AGN) ORDINARY FULLY PAID |
Health Care |
$19 |
Investor Presentation - Cannacord Dug & Device Conference
|
21 Oct 2025 9:04AM |
$0.270 |
$0.145 |
fallen by
46.30%
|
|
| Resouro Strategic Metals Inc (RAU) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$11 |
Resouro Completes First Tranche of Private Placement
|
21 Oct 2025 9:04AM |
$0.325 |
$0.300 |
fallen by
7.69%
|
|
RAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed first tranche of private placement for CAD$1,000,000.
- Issued 5,000,000 units at CAD$0.20 each.
- Units include one common share and one-half warrant.
- Warrants allow purchase of additional share at CAD$0.30 each.
- Proceeds to advance Tiros project and for working capital.
- No finder’s fees paid.
- Pending final approval from TSX Venture Exchange.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Arovella Therapeutics Limited (ALA) ORDINARY FULLY PAID |
Health Care |
$79 |
AusBioInvest Presentation
|
21 Oct 2025 9:03AM |
$0.092 |
$0.065 |
fallen by
29.35%
|
|
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$2,832 |
Update - Notification of buy-back - MFG
|
21 Oct 2025 9:03AM |
$10.350 |
$9.680 |
fallen by
6.47%
|
|
| PMET Resources Inc (PMT) CHESS DEPOSITARY INTERESTS 10:1 |
Materials |
$351 |
Investor Conference Call & Webcast - Feasibility Study
|
21 Oct 2025 9:03AM |
$0.435 |
$0.520 |
risen by
19.54%
|
|
| 5G Networks Limited (5GN) ORDINARY FULLY PAID |
Information Technology |
$15 |
Update - Notification of buy-back - 5GN
|
21 Oct 2025 9:02AM |
$0.140 |
$0.057 |
fallen by
59.29%
|
|
| Nexsen Limited (NXN) ORDINARY FULLY PAID |
Health Care |
$25 |
Nexsen launches clinical trial for GBS Rapid Sensor
|
21 Oct 2025 9:01AM |
$0.275 |
$0.265 |
fallen by
3.64%
|
|
NXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Nexsen Limited, a nano-biotechnology company, is developing the GBS Rapid Sensor marketed as StrepSure®.
- Clinical trials for the GBS Rapid Sensor have commenced, enrolling expectant mothers at Northern Hospital, Epping.
- The GBS Rapid Sensor aims to detect Group B Streptococcus in expectant mothers, potentially replacing current screening methods.
- StrepSure® offers a rapid, accurate, and point-of-care testing option, enhancing maternal and infant health outcomes.
- The trial is spearheaded by Professor Lisa Hui, a prominent expert in maternal-fetal medicine.
- Nexsen is advancing its regulatory, production, and global rollout strategy for the GBS Rapid Sensor.
- The device is expected to support more precise antibiotic use, reduce hospitalization times, and save healthcare costs.
- Nexsen is in partnership with RMIT University for the clinical trial development.
- Initial production of 1,000 investigational devices has been completed and delivered for trial use.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Andean Silver Limited (ASL) ORDINARY FULLY PAID |
Materials |
$414 |
High-grade silver & gold intersections extend mineralisation
|
21 Oct 2025 9:00AM |
$1.955 |
$1.945 |
fallen by
0.51%
|
|
ASL - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling at Cerro Bayo Silver-Gold Project in Chile reveals high-grade silver and gold.
- Intersections of up to 3,224g/t silver and 21.9g/t gold extend known mineralisation.
- New mineralised orientations and previously unmodelled east-west high-grade linking lodes identified.
- Exceptional assays from second phase of drilling targeting main Laguna Verde underground mine complex.
- Drilling includes notable results from Delia SE, Coyita North Splay, and Coyita SE areas.
- Estimated metallurgical recovery rates for gold and silver are 90%, based on past processing records.
- Andean Silver Limited holds 33,180 hectares of Cerro Bayo mine district through its subsidiary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.